supported by grants from the National Key R&D Program of China(2020YFC0860900);the Emergency Key Program of Guangzhou Laboratory(EKPG21-30-4).
Background:The benefits and harms of methylprednisolone treatment in patients with moderate coronavirus disease 2019(COVID-19)remain controversial.In this study,we investigated the effect of methylprednisolone on mort...
the National Natural Science Foundation of China for the financial support(NO.81700317).
Dear Editor,Corona Virus Disease 2019(COVID-19)was first reported in late December 2019,in Wuhan,China.There are over 1,800,000 confirmed cases worldwide.1 The pathological process of severe COVID-19 pneumonia is an i...
Toxic hepatitis due to drugs is an important and frequent drug adverse reaction in clinical practice. Here, we report a case of high dose methylprednisolone-induced acute hepatitis in a 51-year-old woman that suffers ...
ACKNOWLEDGEMENTS This study is supported by the National Natural Science Foundation of China (Nos. 30801039 and 81072424) and the major projects of viral hepatitis from Beijing Municipal Science and Technology Commission (No. H020920020890). We thank the volunteers who generously participated in this study.
Acute-on-chronic liver failure (ACLF) is a severe life-threatening complication. Liver transplantation is the only available therapeutic option; however, several limitations have restricted its use in patients. The ...
A 43-year-old woman with multiple sclerosis (MS) was treated with pulsed methylprednisolone and interferon 13 at a hospital. Four weeks after initiating treatment, liver dysfunction occurred and she was referred and...
Objective To investigate the effects of pulse methylprednisolone (MP) and monthly intravenous cyclophosphamide (CTX) therapy (MP+CTX) on renal infiltrating cells in patients with rapid progressive glomerular nephrit...